Longitudinal Multimodal Assessment of Structure and Function in INPP5E-Related Retinopathy
Genes · 2025
DOI: 10.3390/genes16121407 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Andrea Cusumano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Macula & Genoma Foundation, 00196 Rome, Italy. Hauptthemen laut MEDLINE: Retinal Diseases, Phosphoric Monoester Hydrolases. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
INPP5E-related retinopathy (INPP5E-RR) is a rare genetic disorder caused by biallelic pathogenic variants in the INPP5E gene, which encodes an enzyme critical for phosphoinositide signaling. While early-onset rod–cone dystrophy is a hallmark feature, detailed longitudinal data on the phenotype are scarce. This study aims to report a 6-year longitudinal assessment of retinal structure and function in a case of non-syndromic INPP5E-RR.
Methods
A 42-year-old female proband with compound heterozygous pathogenic missense variants in INPP5E (p.Arg486Cys and p.Arg378Cys) was monitored from 2019 to 2025. She underwent serial comprehensive ophthalmologic evaluations, including optical coherence tomography (OCT), fundus autofluorescence, adaptive optics transscleral flood illumination, full-field 30Hz flicker electroretinography (ERG), and macular frequency-doubling technology perimetry.
Results
Over the 6-year follow-up, OCT imaging revealed a progressive decline in the ellipsoid zone (EZ) width, from 1220 µm to 720 µm (~80 µm/year), and in the inner nuclear layer (INL) thickness. The central outer nuclear layer (ONL) thickness was preserved, but intraretinal cysts developed. Functional testing revealed a progressive decline in cone flicker ERG amplitudes, while visual acuity and macular perimetry remained stable.
Conclusions
In this genotypically confirmed case, the longitudinal data identify EZ width, INL thickness, and cone flicker ERG as robust biomarkers of disease progression in INPP5E-RR. These parameters are ideal candidates for monitoring therapeutic outcomes in future clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Macula & Genoma Foundation, 00196 Rome, Italy.
- Department of Experimental Medicine, Ophthalmology Unit, University of Rome Tor Vergata, 00133 Rome, Italy.
- Macula & Genoma Foundation USA, New York, NY 10017, USA.
- Medical Genetics Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, 00133 Rome, Italy.
- Department of Cardiovascular and Endocrine-Metabolic Diseases and Ageing, National Institute of Health, 00161 Rome, Italy.
ORCID-Profile: Andrea Cusumano, Marco Lombardo, Benedetto Falsini, Jacopo Sebastiani, Enrica Marchionni, Francesco Martelli, Giuseppe Novelli
Zitieren
APA
Cusumano, A., Lombardo, M., Falsini, B., D'Ambrosio, M., Sebastiani, J., Marchionni, E., D'Apice, M. R., Rizzacasa, B., Martelli, F., & Novelli, G. (2025). Longitudinal Multimodal Assessment of Structure and Function in INPP5E-Related Retinopathy. Genes. https://doi.org/10.3390/genes16121407
Vancouver
Cusumano A, Lombardo M, Falsini B, D'Ambrosio M, Sebastiani J, Marchionni E, et al. Longitudinal Multimodal Assessment of Structure and Function in INPP5E-Related Retinopathy. Genes. 2025. doi:10.3390/genes16121407
BibTeX
@article{Cusumano2025,
author = {Cusumano, Andrea and Lombardo, Marco and Falsini, Benedetto and D'Ambrosio, Michele and Sebastiani, Jacopo and Marchionni, Enrica and D'Apice, Maria Rosaria and Rizzacasa, Barbara and Martelli, Francesco and Novelli, Giuseppe},
title = {Longitudinal Multimodal Assessment of Structure and Function in INPP5E-Related Retinopathy},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16121407}
}
EUVIMED